Skip to main content
Caplight Logo









Sencilia B.V.

Sencilia B.V.

Private
GroningenHealthcare & Life Scienceshttps://sencilia.nl

Last Round

Seed

Sep 22, 2025

Total Funding Raised

$1.21M

Company Overview

Sencilia B.V. operates in Healthcare & Life Sciences and is based in Groningen. Its latest recorded funding round was a Seed round in September 2025.

Sencilia B.V. is a medical technology company that develops advanced microelectromechanical systems (MEMS) sensors for real-time intravenous (IV) infusion monitoring to improve patient safety in neonatal and pediatric intensive care units.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Sencilia B.V. Comparables

Compare Sencilia B.V. with similar companies based on industry and business-model similarity.

Sencilia B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DipDop Smart Care Pvt. Ltd.
79%
Monidor
79%
Emsensing Technologies
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Sencilia B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 22, 2025
GrantAug 1, 2024
GrantOct 10, 2023
GrantJul 1, 2023
GrantJul 1, 2022
Pre Seed
Sep 1, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Amar Kamat

Founder and CEO

Founding Team

Felix Wood

Co-CTO

Executive Team

Natanael Gomes

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Sencilia B.V. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors grew 1398% MoM, from 41 to 614.

  • Apr 5, 2026

    Monthly visitors grew 3080% MoM, from 41 to 1.3K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • is_developingNov 12, 2026

    On Nov 12th '26, Sencilia BV is developing Rely-V, a sensor that measures actual IV flow to detect problems earlier in premature babies and children, with production preparation underway, a clinical trial at Erasmus MC expected in Q1 '27, and first products targeted from 2028 onward in the Netherlands.

  • is_developingOct 29, 2026

    Sencilia BV further develops Rely-V(R), an external IV-tube sensor that detects flow issues for infants and children, after raising approximately €2 million to advance its prototype toward production and gather clinical data in the Netherlands on Oct 29th '26.

  • receives_financingOct 29, 2026

    On Oct 29th '26, Sencilia BV receives $2.23M in financing in the Netherlands to further develop its Rely-V(R) sensor technology, with investments from NOM, Future Tech Ventures, imec.istart, RUG Ventures, Triade, and private investors, plus a Eurostars grant and Rabobank innovation loan.

Book a demo to see all news

For institutional investors. Book with your work email.

Sencilia B.V. Filings

Explore SEC and related filing metadata, where available.

Sencilia B.V. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Sencilia B.V.'s valuation, stock price, and market status.

Is Sencilia B.V. a public or private company?

Sencilia B.V. is a private company.

What is the current stock price of Sencilia B.V.?

Sencilia B.V. is a private company, so its shares have no public market price. Caplight tracks Sencilia B.V.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Sencilia B.V. worth (valuation)?

Valuation information for Sencilia B.V. is not publicly available.

Can I buy Sencilia B.V. stock?

Sencilia B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Sencilia B.V.'s last funding round?

Sencilia B.V.'s most recent funding round was Seed on September 22, 2025.

Who are the main investors in Sencilia B.V.?

Key investors in Sencilia B.V. include Future Tech Ventures.

Will Sencilia B.V. IPO soon?

No public IPO plans have been announced for Sencilia B.V..

How can I track Sencilia B.V. secondary market activity?

Caplight tracks bids, offers, and trades in Sencilia B.V.'s shares on secondary markets.

Firmographic Details

HeadquartersGroningen
Employee Range8
Year Founded2021
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?